News & Updates

Glycaemic control not a risk factor for cerebral small vessel disease in T1D
Glycaemic control not a risk factor for cerebral small vessel disease in T1D
16 Mar 2022

Among patients with type 1 diabetes (T1D), medium- and long-term blood glucose control and long-term glycaemic variability do not exert any influence on the risk of developing cerebral small vessel disease, a study has found.

Glycaemic control not a risk factor for cerebral small vessel disease in T1D
16 Mar 2022
Roxadustat proven safe, effective for anaemia in CKD patients
Roxadustat proven safe, effective for anaemia in CKD patients
16 Mar 2022

Treatment with roxadustat leads to significant improvements in renal anaemia among patients with chronic kidney disease (CKD) by increasing haemoglobin (Hb) level and iron metabolism, according to a recent study. However, the risk of serious adverse events (AEs) during treatment must be considered.

Roxadustat proven safe, effective for anaemia in CKD patients
16 Mar 2022